Compare EXLS & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXLS | RGEN |
|---|---|---|
| Founded | 1999 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 8.1B |
| IPO Year | 2004 | 1995 |
| Metric | EXLS | RGEN |
|---|---|---|
| Price | $29.89 | $110.07 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 11 |
| Target Price | $46.80 | ★ $175.64 |
| AVG Volume (30 Days) | ★ 2.0M | 811.6K |
| Earning Date | 04-28-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 27.27 | ★ 286.96 |
| EPS | ★ 1.54 | 0.86 |
| Revenue | ★ $2,087,679,000.00 | $141,236,000.00 |
| Revenue This Year | $12.66 | $14.31 |
| Revenue Next Year | $10.54 | $14.41 |
| P/E Ratio | ★ $19.70 | $132.98 |
| Revenue Growth | 13.56 | ★ 35.10 |
| 52 Week Low | $26.94 | $102.97 |
| 52 Week High | $48.79 | $175.77 |
| Indicator | EXLS | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 38.15 | 30.20 |
| Support Level | $28.62 | N/A |
| Resistance Level | $31.50 | $132.51 |
| Average True Range (ATR) | 0.93 | 4.68 |
| MACD | 0.15 | 0.43 |
| Stochastic Oscillator | 26.92 | 2.57 |
ExlService Holdings Inc. is a data analytics and digital operations company that provides data and AI-led solutions and technology-enabled services to clients across industries. The company has four reportable segments. The Insurance segment provides services such as claims management, underwriting support, and analytics solutions. The Healthcare and Life Sciences segment offers data-driven solutions and services to healthcare payers, providers, and life sciences organizations. The Banking, Capital Markets and Diversified Industries segment delivers solutions across financial services and other industries. The International Growth Markets segment focuses on providing data, AI, and digital operations services to clients outside North America.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.